UniCredit Aktienanleihe S92 28.06.../ DE000HC490U1 /
2024-05-17 1:35:07 PM | Chg.+1.320 | Bid9:59:00 PM | Ask2024-05-17 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
68.740EUR | +1.96% | - Bid Size: - |
- Ask Size: - |
SMA SOLAR TECHNOL.AG | 74.00 - | 2024-06-28 | Call |
GlobeNewswire
2:54 PM
SRCL Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Stericycle to Waste...
Newsfile Corp
2:45 PM
Bassett Furniture Industries, Inc. to Present at Water Tower Research's Inaugural Consumer Products ...
GlobeNewswire
2:42 PM
EXL named a Leader in 2024 Gartner® Magic Quadrant™ for Finance and Accounting Business Process Outs...
GlobeNewswire
2:38 PM
Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tu...
GlobeNewswire
2:35 PM
IBN Announces Latest Episode of The Stock2Me Podcast featuring Brian J. Esposito, CEO of Diamond Lak...
GlobeNewswire
2:31 PM
German American Bancorp, Inc. announces the sale of the assets of German American Insurance, Inc. to...
Newsfile Corp
2:30 PM
GoGold Resources Inc. to Participate in THE Mining Investment Event of the North, Canada's Only Tier...
GlobeNewswire
2:30 PM
Safety Shot, World’s First Beverage to Reduce Blood Alcohol Content, Announces Launch of New 4-Ounce...
GlobeNewswire
2:30 PM
TIAN RUIXIANG Holdings Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement and Receives...
GlobeNewswire
2:30 PM
electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placement...
GlobeNewswire
2:30 PM
Lantheus’ AI-Enabled aPROMISE Now Available on Siemens Healthineers’ syngo.via platform
GlobeNewswire
2:30 PM
FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Cli...
GlobeNewswire
2:30 PM
LIXTE Biotechnology Holdings Names Distinguished Oncologist Jan Schellens as Chief Medical Officer
GlobeNewswire
2:30 PM
Qlik Signs Strategic Collaboration Agreement with AWS to Accelerate Enterprise AI Adoption
GlobeNewswire
2:20 PM
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial